Immuno 2026 Opens with Global Leaders Exploring the Next Decade of Cancer Immunotherapy
WCC 2026 Highlights Growing Focus on Climate Change and the Future of Cancer Care
Global Cancer Leaders Gather in Brussels to Mark 10 Years of World Cancer Research Day
FDA Approved Lirafugratinib for FGFR2 Fusion or Rearrangement–Positive Cholangiocarcinoma
Mike Bloomberg: Honored to be Reappointed as the WHO Global Ambassador for NCDs and Injuries
Sjoerd Hubben: A Call to Strengthen Europe’s Pharma Innovation Ecosystem
Integrated utDNA and ctDNA Testing in Upper Tract Urothelial Carcinoma
Cancer In US Media: 2026
